| Interventions | All Studies, % | Stress UI Studies*, % | Urgency UI Studies*, % | |
|---|---|---|---|---|
| Cure | BTX (onabotulinum toxin A) | 43.6 | . | 42.8 |
| Hormones | 28.3 | 1.7 | . | |
| Anticholinergics | 21.0 | . | 21.4 | |
| Periurethral bulking | 15.6 | 16.9 | . | |
| Alpha agonists | 14.3 | 15.8 | . | |
| Anticholinergics + hormones | 4.6 | . | . | |
| Placebo/Sham/No treatment | 12.0 | 13.3 | 13.2 | |
| Improvement | BTX (onabotulinum toxin A) | 66.6 | . | 75.3 |
| Anticholinergics | 49.4 | 24.9 | 60.1 | |
| Periurethral bulking | 42.1 | 42.3 | . | |
| Alpha agonists | 41.6 | 46.0 | . | |
| Anticholinergics + hormones | 25.2 | . | . | |
| Hormones | 14.9 | 15.9 | . | |
| Placebo/Sham/No treatment | 24.8 | 27.2 | 45.7 | |
| Satisfaction | BTX (onabotulinum toxin A) | 85.5 | . | 59.5 |
| Anticholinergics | 54.7 | . | 48.9 | |
| Alpha agonists | . | . | . | |
| Anticholinergics + hormones | . | . | . | |
| Hormones | . | . | . | |
| Periurethral bulking | . | . | . | |
| Placebo/Sham/No Treatment | 31.8 | 34.9 | 26.9 |
Interventions are sorted by percent of women across all studies who achieved cure (except for no treatment in the last rows). Empty cells (with periods) indicate that the intervention was not evaluated among the studies designated in the given column.
Restricted to studies of the given subgroup of women
From: Results
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.